Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2003
10/01/2003EP1347761A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives
10/01/2003EP1347755A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
10/01/2003EP1347679A1 Method of inactivating viral particles in a blood product
10/01/2003EP1097153B1 Novel triazolo[4,5-d]pyrimidine compounds
10/01/2003EP0999854B1 Switchable viscoelastic systems containing galactomannan polymers and borate
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0996621B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
10/01/2003EP0813525B1 Benzamidine derivatives their preparation and their use as anti-coagulants
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446217A Beta-carboline derivatives useful as inhibitors of phosphodiesterase
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446199A New amidino derivatives and their use as thrombin inhibitors
10/01/2003CN1446103A Treating endotoxemia and related disorders with probiotics
10/01/2003CN1446101A Combination product comprising melagatran and factor VLLa inhibitor
10/01/2003CN1446098A Modulation of alpha-6 integrin-mediated responses
10/01/2003CN1446090A Pharmaceutical composition comprising metformin and 5-phenoxyalkyl-2, 4-thiazolidinedione-type derivative
10/01/2003CN1446084A Treatment of insulin resistance syndrome
10/01/2003CN1446082A ÔÇ£Slow releaseÔÇØ pharmaceutical compositions comprising lithium carbonate
10/01/2003CN1445245A Dermatan sulfate with low molecule and its preparing method
10/01/2003CN1445241A Monochain antibody with dual specificities possessing activity for restraining adherence and aggregation of blood platelets
10/01/2003CN1444963A Medicine for treating thrombus disease
10/01/2003CN1444933A Ethylenediamine Diaceturate injection
10/01/2003CN1122659C Synthesis preparation method of high-effective hemostatic notoginseng extract
09/2003
09/30/2003US6627769 Antiproliferative agents
09/30/2003US6627656 Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful therefore
09/30/2003US6627649 (2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4 -dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2 -carbonyl)pyrrolidine-2-carboxamide, a selective V1a arginine vasopressin receptor antagonist, in combination with the
09/30/2003US6627633 The compounds also are potent inhibitors of human cellular proliferation. As such, the compounds constitute pharmaceutical compositions with a pharmaceutically acceptable carrier. Such compounds are useful in inhibiting cellular
09/30/2003US6627626 Antiinflammation agents and antiarthritic agents colon cancer, and Alzheimer's disease in mammals, preferably humans, dogs, cats and livestock animals.
09/30/2003US6627602 Preventing desensitization of receptors
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627231 Protecting cell from damage caused by free radicals by administering lipophilic antioxidant comprising vitamin E, beta carotene, extract of Lycopersicum esculentum, hydrophilic antioxidant comprising vitamin c, extract of vitis vinifera
09/30/2003US6627213 Administering on the same day the infant is fed human breast milk a supplement free of carbohydrate and comprising casein, salts of casein, whey, and casein hydrolysates; decrease of jaundice and increase of excretion of bilirubin
09/30/2003US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
09/30/2003US6627187 Containing an amino acid as a stabilizer; long term storage stability
09/30/2003US6627186 Treating neutrophil disorders; granulocyte colony stimulating factor (G-CSF)
09/30/2003US6627164 Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
09/30/2003CA2254750C Inhibition of matrix metalloproteases by 2-(.omega.-aroylalkyl)-4-biaryl-oxobutyric acids
09/28/2003CA2379375A1 Sulfonamide derivatives of 3-substituted imidazol[1,2-d]-1,2,4-thiadiazoles and 3-substituted-[1,2,4] thiadiazolo[4,5-a] benzimidazole as inhibitors of fibrin cross-linking and transglutaminases
09/27/2003CA2423550A1 Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient
09/25/2003WO2003078647A2 Aza-benzothiopyranoindazoles with antitumor activity
09/25/2003WO2003078623A1 Functional molecule and process for producing the same
09/25/2003WO2003078427A1 Azolylaminoazines as inhibitors of protein kinases
09/25/2003WO2003078426A1 Azolylaminoazine as inhibitors of protein kinases
09/25/2003WO2003078425A1 Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt
09/25/2003WO2003078413A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
09/25/2003WO2003078409A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
09/25/2003WO2003078394A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003WO2003078389A1 Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
09/25/2003WO2003078386A1 Naphthylsemicarbazone, naphthylhydrazone, naphthylthiosemicarbazone, and naphthylthiohydrazone compounds and therapeutic use thereof
09/25/2003WO2003077946A1 Medicinal agent and method for curing pathologic syndrome associated to hemodyscrasia
09/25/2003WO2003077921A1 Azinylaminoazoles as inhibitors of protein kinases
09/25/2003WO2003077919A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
09/25/2003WO2003077915A1 Use of rapamycin for inhibiting of cell death
09/25/2003WO2003077904A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon
09/25/2003WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/25/2003WO2003077834A2 Central airway administration for systemic delivery of therapeutics
09/25/2003WO2003077832A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003WO2003077723A2 Methods and devices for detection and therapy of atheromatous plaque
09/25/2003WO2003039472A3 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
09/25/2003WO2003039451A3 Thiazole pyridazinones as adenosine antagonists
09/25/2003WO2003011855A3 Pyrazole-derived kinase inhibitors and uses thereof
09/25/2003WO2003008454A3 Glycoprotein vi fusion proteins
09/25/2003WO2003002114A3 Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis
09/25/2003WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89)
09/25/2003WO2002036161A3 Novel targeted compositions for diagnostic and therapeutic use
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002024690A3 Efficient process for the preparation of a factor xa inhibitor
09/25/2003US20030181766 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
09/25/2003US20030181689 Percarboxylated polysaccharides, and a process for their preparation
09/25/2003US20030181659 Thrombopoietin receptor modulating peptide
09/25/2003US20030181519 Substituted phenyl naphthalenes as estrogenic agents
09/25/2003US20030181497 Heterocyclic acridone inhibitors of IMPDH enzyme
09/25/2003US20030181477 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/25/2003US20030181476 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/25/2003US20030181469 Crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
09/25/2003US20030181458 Preferential serotonin receptors antagonists comprising heterocyclic amines used for prophylaxis or prevention of headaches, sleep, sexual or eating disorders and as antidepressants
09/25/2003US20030181440 Isonipecotamides for the treatment of integrin-mediated disorders
09/25/2003US20030181422 Cardioprotective phosphonates and malonates
09/25/2003US20030181417 Nitroderivatives of polysaccharides
09/25/2003US20030181400 Novel disaccharides with anti-arthrosic properties
09/25/2003US20030181389 Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
09/25/2003US20030181388 Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or entire
09/25/2003US20030181381 Factor X analogues having a modified protease cleavage site
09/25/2003US20030181361 Sustained-release pharmaceutical formulations of therapeutic proteins containing carboxymethyl ether cellulose polymer and methods of manufacture and use thereof.
09/25/2003US20030181358 Use a high-molecular-weight extracellular haemoglobin as a blood substitute
09/25/2003US20030180947 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
09/25/2003US20030180934 Plasminogen-like polynucleotides, polypeptides, and antibodies
09/25/2003US20030180877 Gene therapy; drug screening
09/25/2003US20030180404 Methods of treating clinical diseases with isoflavones
09/25/2003US20030180359 Controlled release
09/25/2003US20030180293 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
09/25/2003US20030180288 Methods and compositions for modulating immune response and for the treatment of inflammatory disease
09/25/2003US20030180275 Human serpin polypeptides
09/25/2003CA2479676A1 Dexanabinol and dexanabinol analogs regulate inflammation related genes
09/25/2003CA2479352A1 Carboxylic acid compound and a pharmaceutical agent comprising the compound as an active ingredient
09/25/2003CA2479212A1 Central airway administration for systemic delivery of therapeutics
09/25/2003CA2479062A1 Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
1 ... 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 ... 671